209 related articles for article (PubMed ID: 37990343)
21. Genitourinary cancer.
Hudes GR; Ozols RF; Schilder RJ
Cancer Chemother Biol Response Modif; 1991; 12():509-48. PubMed ID: 1718377
[No Abstract] [Full Text] [Related]
22. Use of immunotherapy in clinical management of genitourinary cancers - a review.
Mar N; Uchio E; Kalebasty AR
Cancer Treat Res Commun; 2022; 31():100564. PubMed ID: 35472699
[TBL] [Abstract][Full Text] [Related]
23. Emerging therapeutic agents for genitourinary cancers.
Zarrabi K; Paroya A; Wu S
J Hematol Oncol; 2019 Sep; 12(1):89. PubMed ID: 31484560
[TBL] [Abstract][Full Text] [Related]
24. Novel therapies in genitourinary cancer: an update.
Chu D; Wu S
J Hematol Oncol; 2008 Aug; 1():11. PubMed ID: 18694493
[TBL] [Abstract][Full Text] [Related]
25. Genitourinary cancer.
Hudes GR; Grana G; Deshields MS; Ozols RF
Cancer Chemother Biol Response Modif; 1992; 13():508-40. PubMed ID: 1389919
[No Abstract] [Full Text] [Related]
26. Recent advances in the use of therapeutic cancer vaccines in genitourinary malignancies.
Surolia I; Gulley J; Madan RA
Expert Opin Biol Ther; 2014 Dec; 14(12):1769-81. PubMed ID: 25212872
[TBL] [Abstract][Full Text] [Related]
27. Immune checkpoint inhibitors in genitourinary malignancies.
Thana M; Wood L
Curr Oncol; 2020 Apr; 27(Suppl 2):S69-S77. PubMed ID: 32368176
[TBL] [Abstract][Full Text] [Related]
28. Genitourinary cancer.
Ozols RF; Yagoda A
Cancer Chemother Biol Response Modif; 1990; 11():602-29. PubMed ID: 2171615
[No Abstract] [Full Text] [Related]
29. Genitourinary cancer.
Ozols RF; Yagoda A
Cancer Chemother Biol Response Modif; 1987; 9():280-302. PubMed ID: 2856337
[No Abstract] [Full Text] [Related]
30. Perception of cure among patients with metastatic genitourinary cancer initiating immunotherapy.
Bergerot CD; Bergerot PG; Philip EJ; Hsu JA; Dizman N; Vaishampayan U; Dorff T; Pal SK
J Immunother Cancer; 2019 Mar; 7(1):71. PubMed ID: 30867071
[TBL] [Abstract][Full Text] [Related]
31. The immunotherapy revolution in genitourinary malignancies.
U Gandhy S; Madan RA; Aragon-Ching JB
Immunotherapy; 2020 Aug; 12(11):819-831. PubMed ID: 32594815
[TBL] [Abstract][Full Text] [Related]
32. Targetable gene fusions and aberrations in genitourinary oncology.
Pederzoli F; Bandini M; Marandino L; Ali SM; Madison R; Chung J; Ross JS; Necchi A
Nat Rev Urol; 2020 Nov; 17(11):613-625. PubMed ID: 33046892
[TBL] [Abstract][Full Text] [Related]
33. Genitourinary cancer in the elderly.
Mulholland SG; Stefanelli JL
Am J Kidney Dis; 1990 Oct; 16(4):324-8. PubMed ID: 2220779
[TBL] [Abstract][Full Text] [Related]
34. Highlights from the Society of Urologic Oncology 4th annual meeting.
Coleman J; Franks ME; Grubb RL; Wynberg J; Lee CS; Behari A; Kim CM; Williams C; Linehan WM
J Urol; 2005 Mar; 173(3):938-41. PubMed ID: 15711343
[TBL] [Abstract][Full Text] [Related]
35. Novel agents and clinical trials in castration-resistant prostate cancer: latest updates from 2023 ASCO-GU Cancers Symposium.
Jiang Y; Wu S; Li R; Yu J; Zheng J; Li Z; Li M; Xin K; Xu Z; Li S; Chen X
Exp Hematol Oncol; 2023 Aug; 12(1):68. PubMed ID: 37528464
[TBL] [Abstract][Full Text] [Related]
36. Effect of Immunotherapy on Local Treatment of Genitourinary Malignancies.
Pignot G; Loriot Y; Kamat AM; Shariat SF; Plimack ER
Eur Urol Oncol; 2019 Jul; 2(4):355-364. PubMed ID: 31277773
[TBL] [Abstract][Full Text] [Related]
37. [DGFIT: Immune and targeted therapy in urologic oncology – what can be expected?].
Hegele A; Heinzer H; Rüttinger D; Siebels M
Aktuelle Urol; 2012 Jul; 43(4):219-26. PubMed ID: 23035262
[TBL] [Abstract][Full Text] [Related]
38. [Towards the individualisation of prescriptions in oncology: urogenital cancers].
Pouessel D; Culine S
Bull Cancer; 2008 Oct; 95(10):975-8. PubMed ID: 19004728
[TBL] [Abstract][Full Text] [Related]
39. Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies.
Marciscano AE; Madan RA
Curr Treat Options Oncol; 2018 Mar; 19(3):16. PubMed ID: 29520448
[TBL] [Abstract][Full Text] [Related]
40. Combination immunotherapy in genitourinary malignancies.
Hoffman-Censits J; Wilde L
Curr Opin Urol; 2016 Nov; 26(6):523-8. PubMed ID: 27517637
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
